EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the Pharmacological Potential of Myricetin: From Therapeutic Applications to Recent Trends in Nanoformulations

Neelam Sharma, Gaurav Malik, Sukhbir Singh, Philips Kumar, Sakshi Verma

Letters in Applied NanoBioScience · 30.06.2026 · 15 (2)

DOI: 10.33263/lianbs152.072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Applied NanoBioScience, online erschienen am 30.06.2026. Verfasst von Neelam Sharma und 4 weiteren Autor:innen. Die Arbeit nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The flavonoids are natural compounds with a polyphenolic structure that are generated from plant metabolites and are frequently present in fruits, vegetables, and some beverages. Myricetin (MYR) has the IUPAC name 3, 5, 7, 3′, 4′, 5′-hexahydroxyflavonol and belongs to the polyhydroxyflavonol. The compound was originally isolated from the bark of the tree Myrica rubra. This review elucidates the uses and principal mechanisms of MYR in anticancer, antidiabetic, anti-inflammatory, antioxidant, anti-Alzheimer's, cardioprotective, and antiepileptic actions. MYR has low solubility, permeability, and bioavailability, which can be addressed through the development of nanotechnology-based formulations that increase surface area, enhance dissolution rates, and facilitate transport across biological barriers. This review provides extensive updates on MYR-loaded nanoformulations such as silver nanoparticles, starch nanoparticles, solid lipid nanoparticles, gold nanoparticles, bovine serum albumin nanoparticles, nanomicelles, liposomes, polymeric micelles, and magnetic nanoparticles. The published patents highlighted the therapeutic applications of MYR for a range of conditions, including oesophageal diseases, viral infections, facial vascularity, bacterial infections, anti-senile dementia activity, Covid-19, coronal pneumonia, as well as anti-cholinesterase and anti-enzyme activities.

Zitieren

APA

Sharma, N., Malik, G., Singh, S., Kumar, P., & Verma, S. (2026). Unraveling the Pharmacological Potential of Myricetin: From Therapeutic Applications to Recent Trends in Nanoformulations. Letters in Applied NanoBioScience, 15(2). https://doi.org/10.33263/lianbs152.072

Vancouver

Sharma N, Malik G, Singh S, Kumar P, Verma S. Unraveling the Pharmacological Potential of Myricetin: From Therapeutic Applications to Recent Trends in Nanoformulations. Letters in Applied NanoBioScience. 2026;15(2). doi:10.33263/lianbs152.072

BibTeX
@article{Sharma2026,
  author = {Sharma, Neelam and Malik, Gaurav and Singh, Sukhbir and Kumar, Philips and Verma, Sakshi},
  title = {Unraveling the Pharmacological Potential of Myricetin: From Therapeutic Applications to Recent Trends in Nanoformulations},
  journal = {Letters in Applied NanoBioScience},
  year = {2026},
  volume = {15},
  number = {2},
  doi = {10.33263/lianbs152.072}
}
Kostenlos starten →